rofecoxib has been researched along with Recrudescence in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 21 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peres, MF; Silberstein, SD | 1 |
| Elmlinger, MW; Plikat, K; Reichle, A; Schölmerich, J | 1 |
| Lisotto, C; Maggioni, F; Mainardi, F; Zanchin, G | 1 |
| Dulai, GS; Gralnek, IM; Spiegel, BM; Targownik, L | 1 |
| Ashwath, ML; Katner, HP | 1 |
| Biancone, L; De Nigris, F; Fantini, M; Pallone, F; Tosti, C | 1 |
| Hawkey, CJ; James, MW | 1 |
| Biancone, L; Emerenziani, S; Fina, D; Geremia, A; Pallone, F; Petruzziello, C; Tosti, C | 1 |
| Antonicelli, L; Bilò, MB; Bonadonna, P; Crivellaro, MA; Dama, AR; Schiappoli, M; Senna, G | 1 |
| Hudson, M; Pilote, L; Richard, H | 1 |
| Asero, R | 1 |
| Abildstrom, SZ; Buch, P; Friberg, J; Gislason, GH; Jacobsen, S; Køber, L; Madsen, M; Rasmussen, JN; Rasmussen, S; Schramm, TK; Torp-Pedersen, C | 1 |
| Brophy, JM; Lévesque, LE; Zhang, B | 1 |
| Mor, M; Niv, G; Niv, Y | 1 |
| Lapner, MA; Stephen, WJ | 1 |
| Han, P; Henry, D; Jones, L; McGettigan, P; Whitaker, D | 1 |
| Simon, B | 1 |
| Barkun, AN; Baron, D; Bombardier, C; Bursey, FR; Hunt, RH; Marshall, JR; Morgan, DG; Paré, P; Thomson, AB; Whittaker, JS | 1 |
| Goh, J; Hunter, JO; Middleton, SJ; Parkes, M; Wight, D | 1 |
| Barbosa, JS; Krymchantowski, AV | 1 |
3 review(s) available for rofecoxib and Recrudescence
| Article | Year |
|---|---|
The cost-effectiveness of cyclooxygenase-2 selective inhibitors in the management of chronic arthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cardiovascular Diseases; Celecoxib; Chronic Disease; Cost-Benefit Analysis; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Decision Support Techniques; Humans; Isoenzymes; Lactones; Membrane Proteins; Osteoarthritis; Peptic Ulcer; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Quality-Adjusted Life Years; Recurrence; Risk Factors; Sensitivity and Specificity; Sulfonamides; Sulfones | 2003 |
Assessment of non-steroidal anti-inflammatory drug (NSAID) damage in the human gastrointestinal tract.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Endoscopy, Gastrointestinal; Gastric Mucosa; Gastrointestinal Diseases; Gastrointestinal Hemorrhage; Humans; Isoenzymes; Lactones; Membrane Proteins; Prognosis; Prostaglandin-Endoperoxide Synthases; Radionuclide Imaging; Randomized Controlled Trials as Topic; Recurrence; Sulfones | 2003 |
Recommendations for the appropriate use of anti-inflammatory drugs in the era of the coxibs: defining the role of gastroprotective agents.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Gastrointestinal Diseases; Humans; Incidence; Lactones; Practice Guidelines as Topic; Predictive Value of Tests; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Sulfones; Treatment Outcome | 2002 |
4 trial(s) available for rofecoxib and Recrudescence
| Article | Year |
|---|---|
Rofecoxib and early relapse of inflammatory bowel disease: an open-label trial.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Colitis, Ulcerative; Crohn Disease; Cyclooxygenase Inhibitors; Female; Humans; Lactones; Male; Middle Aged; Prospective Studies; Recurrence; Sulfones; Treatment Outcome | 2004 |
Tolerability of three selective cyclo-oxygenase-2 inhibitors, meloxicam, celecoxib and rofecoxib in NSAID-sensitive patients.
Topics: Adolescent; Adult; Aged; Angioedema; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Celecoxib; Cross Reactions; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Hypersensitivity; Female; Forced Expiratory Volume; Hemodynamics; Humans; Isoenzymes; Lactones; Male; Meloxicam; Membrane Proteins; Middle Aged; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Recurrence; Rhinitis, Allergic, Perennial; Single-Blind Method; Sulfonamides; Sulfones; Thiazines; Thiazoles; Urticaria | 2004 |
Oral aspirin challenges in patients with a history of intolerance to single non-steroidal anti-inflammatory drugs.
Topics: Acetaminophen; Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Cyclooxygenase Inhibitors; Drug Evaluation; Female; Humans; Lactones; Male; Middle Aged; ortho-Aminobenzoates; Recurrence; Single-Blind Method; Sulfonamides; Sulfones; Tramadol; Urticaria | 2005 |
Rizatriptan combined with rofecoxib vs. rizatriptan for the acute treatment of migraine: an open label pilot study.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Female; Humans; Lactones; Male; Middle Aged; Migraine Disorders; Nausea; Pilot Projects; Prospective Studies; Recurrence; Serotonin Receptor Agonists; Sulfones; Triazoles; Tryptamines | 2002 |
14 other study(ies) available for rofecoxib and Recrudescence
| Article | Year |
|---|---|
Hemicrania continua responds to cyclooxygenase-2 inhibitors.
Topics: Celecoxib; Cyclooxygenase Inhibitors; Female; Humans; Indomethacin; Lactones; Male; Migraine Disorders; Pyrazoles; Recurrence; Sulfonamides; Sulfones | 2002 |
[Hypoglycemia associated with the production of insulin-like growth factor (IGF)-II by a hemangiopericytoma].
Topics: Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Cyclophosphamide; Female; Hemangiopericytoma; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin-Like Growth Factor Binding Protein 2; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Lactones; Liver Neoplasms; Pioglitazone; Prednisolone; Recurrence; Sulfones; Thiazoles; Thiazolidinediones; Time Factors | 2003 |
Rofecoxib for the treatment of chronic paroxysmal hemicrania.
Topics: Cyclooxygenase Inhibitors; Female; Humans; Indomethacin; Lactones; Male; Recurrence; Sulfones; Vascular Headaches | 2003 |
Summaries for patients. The cost-effectiveness of cyclooxygenase-2 inhibitors for treating chronic arthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Celecoxib; Chronic Disease; Cost-Benefit Analysis; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Decision Support Techniques; Humans; Isoenzymes; Lactones; Membrane Proteins; Osteoarthritis; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Quality-Adjusted Life Years; Recurrence; Sensitivity and Specificity; Stomach Ulcer; Sulfonamides; Sulfones | 2003 |
Recurrent aseptic meningitis due to different non-steroidal anti-inflammatory drugs including rofecoxib.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Lactones; Meningitis, Aseptic; Recurrence; Sulfones | 2003 |
Selective cyclooxygenase-2 inhibitors and relapse of inflammatory bowel disease.
Topics: Adult; Aged; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Humans; Inflammatory Bowel Diseases; Isoenzymes; Lactones; Longitudinal Studies; Membrane Proteins; Middle Aged; Prospective Studies; Prostaglandin-Endoperoxide Synthases; Recurrence; Sulfones | 2003 |
Differences in outcomes of patients with congestive heart failure prescribed celecoxib, rofecoxib, or non-steroidal anti-inflammatory drugs: population based study.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Cause of Death; Celecoxib; Cohort Studies; Cyclooxygenase Inhibitors; Female; Heart Failure; Humans; Lactones; Male; Prognosis; Pyrazoles; Recurrence; Risk Factors; Sulfonamides; Sulfones; Survival Analysis | 2005 |
Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Confidence Intervals; Cross-Over Studies; Cyclooxygenase 2 Inhibitors; Denmark; Diclofenac; Dose-Response Relationship, Drug; Female; Humans; Ibuprofen; Lactones; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Odds Ratio; Patient Readmission; Proportional Hazards Models; Pyrazoles; Recurrence; Registries; Retrospective Studies; Risk Factors; Sulfonamides; Sulfones | 2006 |
The coronary risk of cyclo-oxygenase-2 inhibitors in patients with a previous myocardial infarction.
Topics: Aged; Case-Control Studies; Celecoxib; Confounding Factors, Epidemiologic; Cyclooxygenase 2 Inhibitors; Female; Humans; Lactones; Logistic Models; Male; Myocardial Infarction; Pyrazoles; Recurrence; Risk; Sulfonamides; Sulfones | 2007 |
Patient retention in a clinical trial: a lesson from the rofecoxib (VIOXX) study.
Topics: Aged; Aged, 80 and over; Colonic Polyps; Cyclooxygenase 2 Inhibitors; Female; Humans; Lactones; Male; Middle Aged; Multicenter Studies as Topic; Multivariate Analysis; Patient Compliance; Physician-Patient Relations; Predictive Value of Tests; Prospective Studies; Quality of Life; Randomized Controlled Trials as Topic; Recurrence; Sulfones; Surveys and Questionnaires; Treatment Outcome | 2006 |
Rofecoxib associated with diaphragm disease.
Topics: Arthritis, Rheumatoid; Constriction, Pathologic; Cyclooxygenase 2 Inhibitors; Female; Humans; Intestinal Obstruction; Intestine, Small; Lactones; Middle Aged; Recurrence; Sulfones | 2007 |
Selective COX-2 inhibitors, NSAIDs and congestive heart failure: differences between new and recurrent cases.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Celecoxib; Cyclooxygenase 2 Inhibitors; Female; Heart Failure; Hospitalization; Humans; Lactones; Male; Pyrazoles; Recurrence; Risk Factors; Statistics as Topic; Sulfonamides; Sulfones | 2008 |
[Prof. Bernd Simon on nonsteroidal anti-inflammatory drugs. Gastrointestinal complications are unpredictable].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Humans; Lactones; Peptic Ulcer; Recurrence; Risk; Risk Factors; Sulfones | 2001 |
Rofecoxib and cytomegalovirus in acute flare-up of ulcerative colitis: coprecipitants or coincidence?
Topics: Aged; Colitis, Ulcerative; Cyclooxygenase Inhibitors; Cytomegalovirus Infections; Humans; Lactones; Male; Recurrence; Sulfones | 2002 |